Table 2 Clinicopathological features of patients with MSI-H and CNL subtypes
Items/N (%) | All patients in MSI-H and CNL subtypes (N = 187) | Patients with comprehensive genetic testing in MSI-H and CNL subtypes (N = 39) | p value |
|---|---|---|---|
Subtype | Â | Â | 0.45 |
 CNL | 143 (76.47%) | 27 (69.23%) |  |
 MSI-H | 44 (23.53%) | 12 (30.77%) |  |
Age (number) | Â | Â | 0.24 |
 Mean ± SD | 54.25 ± 9.51 | 56.54 ± 8.86 |  |
 Median [min-max] | 54.00 [31.00, 76.00] | 59.00 [31.00, 75.00] |  |
Stage | Â | Â | 0.21 |
 I | 129 (68.98%) | 28 (71.79%) |  |
 II | 14 (7.49%) | 1 (2.56%) |  |
 III | 24 (12.83%) | 9 (23.08%) |  |
 IV | 2 (1.07%) | 0 (0.00%) |  |
 Unknow | 18 (9.63%) | 1 (2.56%) |  |
LVSI | Â | Â | 0.08 |
 Yes | 6 (3.21%) | 3 (7.69%) |  |
 No | 142 (75.94%) | 33 (84.62%) |  |
 Unknown | 39 (20.86%) | 3 (7.69%) |  |
Histology Subtype | Â | Â | 0.11 |
 Endometrioid | 153 (81.82%) | 38 (97.44%) |  |
 Serous | 3 (1.60%) | 1 (2.56%) |  |
 others | 5 (2.67%) | 0 (0.00%) |  |
 Unknown | 26 (13.90%) | 0 (0.00%) |  |
Grade |  |  | < 0.01 |
 G1 | 84 (44.92%) | 10 (25.64%) |  |
 G2 | 48 (25.67%) | 16 (41.03%) |  |
 G3 | 25 (13.37%) | 12 (30.77%) |  |
 Undifferentiated | 2 (1.07%) | 1 (2.56%) |  |
 Unknown | 28 (14.97%) | 0 (0.00%) |  |
OS | Â | Â | 0.75 |
 Mean ± SD | 66.18 ± 24.35 | 75.21 ± 31.23 |  |
 Median [min-max] | 67.00 [7.00, 122.00] | 74.00 [7.00, 121.00] |  |